scholarly journals The effect of the area proportion of the metastatic lesion within the central metastatic lymph node on response to therapy in papillary thyroid carcinoma

2021 ◽  
Vol 21 (4) ◽  
Author(s):  
Liuhong Shi ◽  
Liang Zhou ◽  
Jianbiao Wang ◽  
Lei Jin ◽  
Yinjiao Lei ◽  
...  
2005 ◽  
Vol 119 (2) ◽  
pp. 155-157 ◽  
Author(s):  
Chisato Tomoda ◽  
Fumio Matsuzuka ◽  
Akira Miyauchi

We report a case of a parapharyngeal cystic metastatic lymph node arising from papillary thyroid carcinoma (PTC). Parapharyngeal metastases arising from PTC are rare and correct diagnosis of the parapharyngeal mass before surgery is difficult. In this case, the diagnosis of a parapharyngeal mass was made pre-operatively by thyroglobulin measurement in peroral fine-needle aspiration with negative cytology.


2011 ◽  
pp. P3-663-P3-663
Author(s):  
Jonathan Yip ◽  
Steven Orlov ◽  
David Orlov ◽  
Daniel Etarsky ◽  
Davis Tam ◽  
...  

2012 ◽  
Vol 147 (2_suppl) ◽  
pp. P166-P166
Author(s):  
Min-Seok Jang ◽  
Young-Ik Son ◽  
Jeong-Hwan Baek ◽  
Ki-Nam Park ◽  
Dohun Kim

2021 ◽  
pp. 019459982199146
Author(s):  
Jungirl Seok ◽  
Chang Hwan Ryu ◽  
Seog Yun Park ◽  
Chang Yoon Lee ◽  
Young Ki Lee ◽  
...  

Objective Despite the growing evidence that metastatic lymph node ratio (MLNR) is a valuable predictor for the prognosis of papillary thyroid carcinoma, it has not yet been fully determined which factors give the ratio predictive value independent of the number of metastatic lymph nodes (MLNs). Study Design Retrospective cohort study. Setting A comprehensive cancer center. Methods Recurrence and clinicopathologic factors were analyzed in 2409 patients with papillary thyroid carcinoma who underwent total thyroidectomy and central node dissection. Results Cutoff values of MLNs ≥2 and MLNR ≥28.2% increased the recurrence risk (hazard ratio [95% CI], 9.97 [4.73-21.0] and 11.4 [5.53-23.3], respectively). Younger age, male sex, multifocality, tumor size, lymphatic and vascular invasion, and gross extrathyroidal extension positively correlated with MLN and MLNR (all P < .05). Meanwhile, lymphocytic thyroiditis negatively correlated with MLNR in female patients ( P < .001), by increasing total lymph node yields as compared with papillary thyroid carcinoma without lymphocytic thyroiditis. In multivariate analysis, younger age, tumor size, and lymphatic invasion remained significant in male and female patients for MLN and MLNR; lymphocytic thyroiditis was also significantly correlated with MLNR in female patients. Conclusion Our study demonstrates that MLN and MLNR are independently observed prognostic markers for tumor recurrence. However, lymphocytic thyroiditis in female patients seems to have lower MLNR by increasing total lymph node yields. In light of their association, a different cutoff for MLNR needs to be applied according to the presence or absence of underlying lymphocytic thyroiditis in the use of MLNR for predicting the recurrence. Level of Evidence: 4.


2008 ◽  
Vol 52 (7) ◽  
pp. 1194-1200 ◽  
Author(s):  
Graciela A. de Cross ◽  
Horacio Suarez ◽  
Fabián Pitoia ◽  
Daniel Moncet ◽  
María Vanegas ◽  
...  

A 29 yrs-old patient was referred to our hospital due to generalized convulsions. She had hyperthyroidism treated with methimazole. Her MRI showed 4 metastatic lesions in the brain. She had a goiter with a "cold" nodule and a palpable ipsilateral lymph node. The FNAB disclosed a papillary thyroid carcinoma. Under 5 mg of MMI treatment, she had a subclinical hyperthyroidism and TRAb were 47.8% (n.v. < 10%). The CT scan also showed lung metastasis. She underwent a total thyroidectomy with a modified neck dissection and she received an accumulated radioiodine dose of 700 mCi during the following two years. She died from the consequences of multiple metastatic lesions. Studies were performed in DNA extracted from paraffin-embedded tissue from the tumor, the metastatic lymph node and the non-tumoral thyroid. The genetic analysis of tumoral DNA revealed point mutations in two different genes: the wild type CAA at codon 61 of N-RAS mutated to CAT, replacing glycine by histidine (G61H) and the normal GCC sequence at codon 623 of the TSHR gene was replaced by TCC, changing the alanine by serine (A623S). In the non-tumoral tissue no mutations were found. In vitro studies showed a constitutive activation of the TSHR. It is very probable that this activating mutation of the TSHR is unable to reach the end point of the PKA cascade in the tumoral tissue. One possibility that could explain this is the presence of a cross-signaling mechanism generating a deviation of the TSH receptor cascade to the more proliferative one involving the MAPKinase, giving perhaps a more aggressive behavior of this papillary thyroid cancer.


Sign in / Sign up

Export Citation Format

Share Document